Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients
Miquel-Cases, Anna, Retèl, Valesca P, Lederer, Bianca, von Minckwitz, Gunter, Steuten, Lotte M G, van Harten, Wim H
Published in PloS one (28.04.2016)
Published in PloS one (28.04.2016)
Get full text
Journal Article
Decisions on Further Research for Predictive Biomarkers of High-Dose Alkylating Chemotherapy in Triple-Negative Breast Cancer: A Value of Information Analysis
Miquel-Cases, Anna, MPharm, MSc, Retèl, Valesca P., PhD, van Harten, Wim H., MD, PhD, Steuten, Lotte M.G., PhD
Published in Value in health (01.06.2016)
Published in Value in health (01.06.2016)
Get full text
Journal Article
Imaging performance in guiding response to neoadjuvant therapy according to breast cancer subtypes: A systematic literature review
Lindenberg, Melanie A, Miquel-Cases, Anna, Retèl, Valesca P, Sonke, Gabe S, Wesseling, Jelle, Stokkel, Marcel P.M, van Harten, Wim H
Published in Critical reviews in oncology/hematology (01.04.2017)
Published in Critical reviews in oncology/hematology (01.04.2017)
Get full text
Journal Article
Cost-effectiveness of physical activity in the management of COPD patients in the UK
Ramos, Mafalda, Lamotte, Mark, Gerlier, Laetitia, Svangren, Per, Miquel-Cases, Anna, Haughney, John
Published in International journal of chronic obstructive pulmonary disease (01.01.2019)
Published in International journal of chronic obstructive pulmonary disease (01.01.2019)
Get full text
Journal Article
Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy
Miquel-Cases, Anna, Steuten, Lotte M.G, Retèl, Valesca P, van Harten, Wim H
Published in Breast (Edinburgh) (01.08.2015)
Published in Breast (Edinburgh) (01.08.2015)
Get full text
Journal Article